Robert Green, MD, MPH, of the Division of Genetics, received a research grant from the National Institutes of Health (NIH) to fund The BabySeq Project: Phase II, also known as BabySeq2, the continuation of a project to study genome sequencing in newborns.
The original BabySeq Project was a clinical trial created to measure the utility of using genomic sequencing in routine newborn screening. In phase two of the project, Green and his research colleagues hope to expand genomic sequencing to a greater population of newborns, with a focus on serving under-represented minorities. Green co-leads both projects with Ingrid Holm, MD, MPH, of Boston Children's Hospital.
More broadly at the Brigham, Green directs the Genomes2People Research Program and the Precision Population Health Initiative through Ariadne Labs, where he explores the medical, behavioral and economic impact of using genomic information in medicine and society at large. Green is internationally recognized for research and policy efforts accelerating the implementation of genomic medicine, and recently founded the Brigham Preventive Genomics Clinic, the first academic clinic in the world to provide comprehensive DNA sequencing and interpretation to healthy adults and children.